{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:32:24Z","timestamp":1793367144991,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI28697"],"award-info":[{"award-number":["P30AI28697"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI149504"],"award-info":[{"award-number":["U19AI149504"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI126623"],"award-info":[{"award-number":["UM1 AI126623"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R21AI140866"],"award-info":[{"award-number":["1R21AI140866"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI172727"],"award-info":[{"award-number":["R01AI172727"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R2120200174"],"award-info":[{"award-number":["R2120200174"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-10748"],"award-info":[{"award-number":["DISC2-10748"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["K12 GM106996"],"award-info":[{"award-number":["K12 GM106996"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["109577-62-RGRL"],"award-info":[{"award-number":["109577-62-RGRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["110304-71-RKRL"],"award-info":[{"award-number":["110304-71-RKRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["110395-72-RPRL"],"award-info":[{"award-number":["110395-72-RPRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["110038-67-RSRL"],"award-info":[{"award-number":["110038-67-RSRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016951","name":"UCLA AIDS Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010296","name":"James B. Pendleton Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005366","name":"American Foundation for Aging Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA-52841"],"award-info":[{"award-number":["R01DA-52841"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R21AI172582"],"award-info":[{"award-number":["R21AI172582"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U19 HL156247"],"award-info":[{"award-number":["U19 HL156247"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 AI170214"],"award-info":[{"award-number":["R01 AI170214"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 AI167004"],"award-info":[{"award-number":["R01 AI167004"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["\/ ORIP P51 OD010425"],"award-info":[{"award-number":["\/ ORIP P51 OD010425"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U42 OD011123"],"award-info":[{"award-number":["U42 OD011123"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002214","name":"McCarthy Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002214","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016958","name":"Office of Research Infrastructure Programs","doi-asserted-by":"publisher","award":["P51 OD010425"],"award-info":[{"award-number":["P51 OD010425"]}],"id":[{"id":"10.13039\/100016958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016958","name":"Office of Research Infrastructure Programs","doi-asserted-by":"publisher","award":["U42 OD011123"],"award-info":[{"award-number":["U42 OD011123"]}],"id":[{"id":"10.13039\/100016958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA239261-01"],"award-info":[{"award-number":["1R01CA239261-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ymthe.2024.02.026","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T23:22:02Z","timestamp":1708989722000},"page":"1000-1015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Stem cell-derived CAR T\u00a0cells show greater persistence, trafficking, and viral control compared to ex\u00a0vivo transduced CAR T\u00a0cells"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3430-1226","authenticated-orcid":false,"given":"Mayra A.","family":"Carrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjie","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Rezek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Kitchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.02.026_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.02.026_bib2","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1182\/blood-2014-12-580068","article-title":"CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib3","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.02.026_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1006\/mthe.2002.0611","article-title":"A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy","volume":"5","author":"Deeks","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.026_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V96.3.785.015k10_785_793","article-title":"Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T\u00a0cells in human immunodeficiency virus-infected subjects","volume":"96","author":"Mitsuyasu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fcimb.2020.00410","article-title":"Engineering CAR T Cells to Target the HIV Reservoir","volume":"10","author":"Mu","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib7","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T\u00a0cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.02.026_bib8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T\u00a0cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.02.026_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ymthe.2016.12.023","article-title":"Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells","volume":"25","author":"Hale","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.026_bib10","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1128\/JVI.00474-15","article-title":"Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity","volume":"89","author":"Liu","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fimmu.2018.00492","article-title":"Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication","volume":"9","author":"Haran","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006613","article-title":"Supraphysiologic control over HIV-1 replication mediated by CD8 T\u00a0cells expressing a re-engineered CD4-based chimeric antigen receptor","volume":"13","author":"Leibman","year":"2017","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.02.026_bib13","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41591-020-1039-5","article-title":"Dual CD4-based CAR T\u00a0cells with distinct costimulatory domains mitigate HIV pathogenesis in\u00a0vivo","volume":"26","author":"Maldini","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.02.026_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.omtm.2022.04.007","article-title":"Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T\u00a0cells with CMV vaccine. Molecular therapy","volume":"25","author":"Guan","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.02.026_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fimmu.2020.00361","article-title":"Advances in Developing CAR T-Cell Therapy for HIV Cure","volume":"11","author":"Qi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5685","article-title":"Multispecific anti-HIV duoCAR-T cells display broad in\u00a0vitro antiviral activity and potent in\u00a0vivo elimination of HIV-infected cells in a humanized mouse model","volume":"11","author":"Anthony-Gonda","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.02.026_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161698","article-title":"In\u00a0vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T\u00a0cells","volume":"7","author":"Anthony-Gonda","year":"2022","journal-title":"JCI insight"},{"key":"10.1016\/j.ymthe.2024.02.026_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910828","article-title":"Improving CAR T-Cell Persistence","volume":"22","author":"Pietrobon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.02.026_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248973","article-title":"Evaluation of chimeric antigen receptor T\u00a0cell therapy in non-human primates infected with SHIV or SIV","volume":"16","author":"Iwamoto","year":"2021","journal-title":"PloS one"},{"key":"10.1016\/j.ymthe.2024.02.026_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009831","article-title":"CAR\/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection","volume":"18","author":"Pampusch","year":"2022","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.02.026_bib21","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.2020006372","article-title":"Robust expansion of HIV CAR T\u00a0cells following antigen boosting in ART-suppressed nonhuman primates","volume":"136","author":"Rust","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib22","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2018-11-883710","article-title":"Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy","volume":"133","author":"Hay","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878209","article-title":"CAR-T Cell Performance: How to Improve Their Persistence?","volume":"13","author":"L\u00f3pez-Cantillo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1089\/hum.2012.202","article-title":"Modification of hematopoietic stem\/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy","volume":"24","author":"De Oliveira","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.02.026_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/hum.2018.180","article-title":"A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor-Modified Hematopoietic Stem Cells for Cancer Therapy","volume":"30","author":"Kao","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.02.026_bib26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mt.2015.102","article-title":"HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells","volume":"23","author":"Zhen","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.026_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006753","article-title":"Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T\u00a0cells in a nonhuman primate model of HIV\/AIDS","volume":"13","author":"Zhen","year":"2017","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.02.026_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.141502","article-title":"Stem cell-derived CAR T\u00a0cells traffic to HIV reservoirs in macaques","volume":"6","author":"Barber-Axthelm","year":"2021","journal-title":"JCI insight"},{"key":"10.1016\/j.ymthe.2024.02.026_bib29","article-title":"Robust CAR-T memory formation and function via hematopoietic stem cell delivery","volume":"17","author":"Zhen","year":"2021","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.02.026_bib30","first-page":"54048","article-title":"Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model","author":"Zhen","year":"2016","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2024.02.026_bib31","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2326-6066.CIR-17-0405","article-title":"Reducing Ex\u00a0Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells","volume":"6","author":"Ghassemi","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2024.02.026_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/bloodadvances.2017011254","article-title":"Improving T-cell expansion and function for adoptive T-cell therapy using ex\u00a0vivo treatment with PI3Kdelta inhibitors and VIP antagonists","volume":"2","author":"Petersen","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2024.02.026_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40425-017-0227-4","article-title":"Ex\u00a0vivo Akt inhibition promotes the generation of potent CD19CAR T\u00a0cells for adoptive immunotherapy","volume":"5","author":"Urak","year":"2017","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.02.026_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/CJI.0000000000000199","article-title":"Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions","volume":"41","author":"Lee","year":"2018","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2024.02.026_bib35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s13238-019-0643-y","article-title":"Chimeric antigen receptor T (CAR-T) cells expanded with IL-7\/IL-15 mediate superior antitumor effects","volume":"10","author":"Zhou","year":"2019","journal-title":"Protein\u00a0& cell"},{"key":"10.1016\/j.ymthe.2024.02.026_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-009-0573-0","article-title":"IL-7\u00a0+ IL-15 are superior to IL-2 for the ex\u00a0vivo expansion of 4T1 mammary carcinoma-specific T\u00a0cells with greater efficacy against tumors in\u00a0vivo","volume":"122","author":"Cha","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ymthe.2024.02.026_bib37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2012-05-431718","article-title":"IL-7 and IL-15 instruct the generation of human memory stem T\u00a0cells from naive precursors","volume":"121","author":"Cieri","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/hgtb.2014.004","article-title":"Manufacture of gene-modified human T-cells with a memory stem\/central memory phenotype","volume":"25","author":"Gomez-Eerland","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2024.02.026_bib39","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00262-009-0666-y","article-title":"Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1\u00a0+ ionomycin in IL-7\u00a0+ IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2","volume":"58","author":"Le","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2024.02.026_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.omtm.2017.11.008","article-title":"Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1. Molecular therapy","volume":"9","author":"Khamaikawin","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.02.026_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053492","article-title":"Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem\/progenitor cells in humanized BLT mice","volume":"7","author":"Ringpis","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.ymthe.2024.02.026_bib42","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.celrep.2016.02.022","article-title":"IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle","volume":"14","author":"Coiras","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.02.026_bib43","doi-asserted-by":"crossref","first-page":"E9659","DOI":"10.1073\/pnas.1806695115","article-title":"IL-15 regulates susceptibility of CD4(+) T\u00a0cells to HIV infection","volume":"115","author":"Manganaro","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.02.026_bib44","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1182\/blood-2013-06-506949","article-title":"BLT-humanized C57BL\/6 Rag2-\/-gammac-\/-CD47-\/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection","volume":"122","author":"Lavender","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood-2013-01-482224","article-title":"Positive selection of mC46-expressing CD4+ T\u00a0cells and maintenance of virus specific immunity in a primate AIDS model","volume":"122","author":"Younan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib46","article-title":"Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T\u00a0cell therapy","volume":"9","author":"Nissani","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.02.026_bib47","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2016.71.3024","article-title":"Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels","volume":"35","author":"Kochenderfer","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib48","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","article-title":"Homeostasis of naive and memory T\u00a0cells","volume":"29","author":"Surh","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.02.026_bib49","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1182\/blood-2008-10-186601","article-title":"IL-7 administration drives T\u00a0cell-cycle entry and expansion in HIV-1 infection","volume":"113","author":"Sereti","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4049\/jimmunol.180.1.350","article-title":"IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T\u00a0cell responses","volume":"180","author":"Mueller","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/cmi.2014.49","article-title":"Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis","volume":"12","author":"Hou","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/cid\/cis383","article-title":"Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I\/IIa randomized, placebo-controlled, multicenter study","volume":"55","author":"L\u00e9vy","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.02.026_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2011.01.011","article-title":"IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology","volume":"144","author":"Pellegrini","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.02.026_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: Overcoming the challenges of T\u00a0cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2024.02.026_bib55","article-title":"Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T\u00a0cells for relapsed\/refractory CLL","volume":"5","author":"Geyer","year":"2019","journal-title":"JCI insight"},{"key":"10.1016\/j.ymthe.2024.02.026_bib56","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.ymthe.2017.07.004","article-title":"Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy","volume":"25","author":"Kochenderfer","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.026_bib57","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ymthe.2017.05.012","article-title":"CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma","volume":"25","author":"Heczey","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.02.026_bib58","first-page":"472","article-title":"Hemolytic uremic syndrome as a presenting form of HIV infection","volume":"72","author":"Badesha","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.ymthe.2024.02.026_bib59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5414\/CNP71563","article-title":"Hemolytic uremic syndrome as a primary manifestation of acute human immunodeficiency virus infection","volume":"71","author":"Gomes","year":"2009","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib60","first-page":"406","article-title":"Renal pathology of human immunodeficiency virus infection","volume":"18","author":"D'Agati","year":"1998","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s004670050249","article-title":"A typical hemolytic uremic syndrome in human immunodeficiency virus-1-infected children","volume":"11","author":"Turner","year":"1997","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib62","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00002030-199509050-00022","article-title":"Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in HIV-infected patients","volume":"9","author":"Bachmeyer","year":"1995","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.ymthe.2024.02.026_bib63","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1182\/blood.V80.8.1890.bloodjournal8081890","article-title":"Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic","volume":"80","author":"Thompson","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib64","first-page":"15","article-title":"Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption","volume":"26","author":"Mittelman","year":"1989","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1742-4690-6-65","article-title":"Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus","volume":"6","author":"Ho","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.ymthe.2024.02.026_bib66","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/QAD.0000000000000702","article-title":"Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation","volume":"29","author":"Peterson","year":"2015","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.ymthe.2024.02.026_bib67","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41591-021-01497-1","article-title":"CAR T\u00a0cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial","volume":"27","author":"Cordoba","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.02.026_bib68","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.15195","article-title":"Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB","volume":"181","author":"Li","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib69","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","article-title":"Gene therapy using haematopoietic stem and progenitor cells","volume":"22","author":"Ferrari","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2024.02.026_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.02.026_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.02.026_bib72","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.02.026_bib73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa2109167","article-title":"Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease","volume":"386","author":"Goyal","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.02.026_bib74","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2352-3018(20)30069-2","article-title":"Evidence for HIV-1 cure after CCR5Delta32\/Delta32 allogeneic haemopoietic stem-cell transplantation 30\u00a0months post analytical treatment interruption: a case report","volume":"7","author":"Gupta","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ymthe.2024.02.026_bib75","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5Delta32\/Delta32 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.02.026_bib76","article-title":"Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice","volume":"188","author":"Mu","year":"2022","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2024.02.026_bib77","article-title":"Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells","volume":"144","author":"Radtke","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2024.02.026_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.7","article-title":"Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in\u00a0vivo selection after SHIV infection in a nonhuman primate model of AIDS. Molecular therapy","volume":"3","author":"Peterson","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.02.026_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91230","article-title":"Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation","volume":"2","author":"Peterson","year":"2017","journal-title":"JCI insight"},{"key":"10.1016\/j.ymthe.2024.02.026_bib80","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00095-17","article-title":"Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian\/Human Immunodeficiency Virus Viremia","volume":"91","author":"Reeves","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jmp.12060","article-title":"Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection","volume":"42","author":"Peterson","year":"2013","journal-title":"J.\u00a0Med. Primatol."},{"key":"10.1016\/j.ymthe.2024.02.026_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006956","article-title":"Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy","volume":"14","author":"Peterson","year":"2018","journal-title":"PLoS Pathog."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:47:22Z","timestamp":1778816842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1525001624000959"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.02.026","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell-derived CAR T\u00a0cells show greater persistence, trafficking, and viral control compared to ex\u00a0vivo transduced CAR T\u00a0cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}]}}